Microbiome Drugs Market Revenue 2024 to 2034
Microbiome Drugs Market Revenue 2024 to 2034
The Microbiome Drugs Market is projected to grow from USD 15.43 Bn in 2024 to USD 71.79 Bn by 2034, registering a CAGR of 16.62%. Growth is fueled by advancements in microbiome therapeutics, rising R&D investments, and increasing applications in chronic disease management worldwide.
Report ID: 10320
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 15.43 Bn
Forecast Year,
USD 71.79 Bn
CAGR, 2025 -
16.62%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Microbiome Drugs Market Size Analysis
Microbiome Drugs Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 4.94 | 5.74 | 6.78 | 7.84 | 9.13 | 10.62 | 12.42 | 14.45 | 16.88 | 19.59 | 22.84 |
| Biologics | 5.25 | 6.14 | 7.07 | 8.31 | 9.66 | 11.28 | 13.14 | 15.33 | 17.79 | 20.81 | 24.37 |
| Advanced Therapies | 2.78 | 3.24 | 3.75 | 4.37 | 5.09 | 5.97 | 6.94 | 8.11 | 9.52 | 11.11 | 12.96 |
| Others | 2.47 | 2.88 | 3.39 | 3.96 | 4.66 | 5.42 | 6.32 | 7.37 | 8.60 | 10.05 | 11.62 |
Microbiome Drugs Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 5.56 | 6.50 | 7.64 | 8.93 | 10.41 | 12.19 | 14.21 | 16.63 | 19.39 | 22.58 | 26.29 |
| Cardio-Metabolic | 2.78 | 3.24 | 3.75 | 4.37 | 5.11 | 5.96 | 6.95 | 8.10 | 9.43 | 11.03 | 12.83 |
| Infectious | 2.47 | 2.86 | 3.30 | 3.86 | 4.50 | 5.23 | 6.11 | 7.07 | 8.24 | 9.55 | 11.14 |
| CNS | 2.16 | 2.52 | 2.94 | 3.42 | 3.99 | 4.65 | 5.44 | 6.33 | 7.41 | 8.63 | 10.06 |
| Others | 2.47 | 2.89 | 3.35 | 3.89 | 4.53 | 5.24 | 6.10 | 7.14 | 8.32 | 9.77 | 11.46 |
Microbiome Drugs Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 6.79 | 7.94 | 9.27 | 10.84 | 12.73 | 14.81 | 17.23 | 19.98 | 23.41 | 27.25 | 31.91 |
| Retail Pharmacy | 5.56 | 6.49 | 7.56 | 8.80 | 10.26 | 11.99 | 13.99 | 16.44 | 19.08 | 22.28 | 25.89 |
| Online/Other | 3.09 | 3.56 | 4.15 | 4.83 | 5.56 | 6.48 | 7.60 | 8.85 | 10.30 | 12.03 | 13.99 |
Microbiome Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 6.17 | 7.18 | 8.37 | 9.75 | 11.35 | 13.25 | 15.42 | 17.96 | 20.87 | 24.34 | 28.29 |
| Europe | 4.32 | 5.05 | 5.88 | 6.87 | 8.00 | 9.30 | 10.86 | 12.66 | 14.87 | 17.29 | 20.22 |
| Asia Pacific | 3.70 | 4.33 | 5.05 | 5.89 | 6.91 | 8.07 | 9.43 | 11.01 | 12.79 | 14.94 | 17.46 |
| Latin America | 0.62 | 0.72 | 0.84 | 0.97 | 1.13 | 1.32 | 1.55 | 1.80 | 2.11 | 2.48 | 2.88 |
| Middle East & Africa | 0.62 | 0.72 | 0.85 | 0.98 | 1.15 | 1.34 | 1.56 | 1.83 | 2.14 | 2.50 | 2.94 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
